Compliance with guidelines and correlation with outcome in patients with advanced germ-cell tumours

European Journal of Cancer

Volumn 50, Issue 7, 2014, Pages 1284-1290

  Thibault, Constance ^a   Fizazi, Karim ^a   Barrios, Daniel ^a   Massard, Christophe ^a   Albiges, Laurence ^a   Baumert, Herve ^b   Patard, Jean Jacques ^c   Escudier, Bernard ^a   Loriot, Yohann ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b SAINT JOSEPH HOSPITAL   (France)

^c BICÊTRE HOSPITAL   (France)

Author keywords

Adult; Germ cell tumours; Guidelines; Neoplasms

Indexed keywords

ADULT; ARTICLE; CANCER RECURRENCE; GERM CELL TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK FACTOR; SALVAGE THERAPY; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; GERM-CELL TUMOURS; GUIDELINES; NEOPLASMS;

ADULT; ANTINEOPLASTIC AGENTS; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS, GERM CELL AND EMBRYONAL; PRACTICE GUIDELINES AS TOPIC; RECURRENCE; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84897437785     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.01.026     Document Type: Article

References (29)

1. A. Rosen, G. Jayram, M. Drazer, and S.E. Eggener Global trends in testicular cancer incidence and mortality Eur Urol 60 2011 374 379
2. Howlader N, Noone A, Krapcho M, Neyman N, Aminou R, Altekruse S, et al. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/csr/1975-2009-pops09/ 2012.
3. R. De Wit, and K. Fizazi Controversies in the management of clinical stage I testis cancer J Clin Oncol 24 2006 5482 5492
4. K. Fizazi, S. Culine, J.P. Droz, A. Kramar, C. Théodore, and P. Ruffié et al. Primary mediastinal nonseminomatous germ cell tumors: results of modern therapy including cisplatin-based chemotherapy J Clin Oncol 16 1998 725 732
5. International Prognostic Factors Study Group A. Lorch, J. Beyer, C. Bascoul-Mollevi, A. Kramar, and L.H. Einhorn et al. Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy J Clin Oncol 28 2010 4906 4911
6. A. Lorch, C. Bascoul-Mollevi, A. Kramar, L. Einhorn, A. Necchi, and C. Massard et al. Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database J Clin Oncol 29 2011 2178 2184
7. G.M. Boland, G.J. Chang, A.B. Haynes, Y.-J. Chiang, R. Chagpar, and Y. Xing et al. Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer Cancer 119 2013 1593 1601
8. B.C. Visser, Y. Ma, Y. Zak, G.A. Poultsides, J.A. Norton, and K.F. Rhoads Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes HPB (Oxford) 14 2012 539 547
9. I. Ray-Coquard, P. Thiesse, D. Ranchère-Vince, F. Chauvin, J.-Y. Bobin, and M.-P. Sunyach et al. Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas Ann Oncol 15 2004 307 315
10. R. Clasby, K. Tilling, M.A. Smith, and C.D. Fletcher Variable management of soft tissue sarcoma: regional audit with implications for specialist care Br J Surg 84 1997 1692 1696
11. A.A. Bhangu, J.A.S. Beard, and R.J. Grimer Should soft tissue sarcomas be treated at a specialist centre? Sarcoma 8 2004 1 6
12. A. Rydholm Improving the management of soft tissue sarcoma. Diagnosis and treatment should be given in specialist centres BMJ 317 1998 93 94
13. H.J. Schmoll, R. Souchon, S. Krege, P. Albers, J. Beyer, and C. Kollmannsberger et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG) Ann Oncol 15 2004 1377 1399
14. S. Krege, J. Beyer, R. Souchon, P. Albers, W. Albrecht, and F. Algaba et al. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG) Eur Urol 53 2008 478 513
15. Culine S, Hoppe S, Hennequin C, Saves M, Mottet N. Management of testicular neoplasms in France and compliance with national guidelines. Poster presented at: ASCO Annual Meeting; 2010 June 4-8; Chicago.
16. S.B. Edge, and C.C. Compton The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM Ann Surg Oncol 17 2010 1471 1474
17. International Germ Cell Cancer Collaborative Group International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers J Clin Oncol 15 1997 594 603
18. J. Baron, O. Cussenot, E. Fontaine, O. Haillot, J. Hubert, and V. Molinié et al. Recommandation: tumeurs du testicule Comité de Cancérologie de l'AFU 8 1998 65 79
19. A. Houlgatte, D. Chautard, S. Culine, F. Iborra, G. Kouri, and A. Lesourd et al. Recommandation: tumeurs du testicule Comité de Cancérologie de l'AFU 12 2002 69 78
20. S.-E. Olofsson, T. Tandstad, M. Jerkeman, O. Dahl, O. Ståhl, and O. Klepp et al. Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group J Clin Oncol 29 2011 2032 2039
21. Fizazi K, Pagliaro LC, Flechon A, Mardiak J. Combination chemotherapy in treating patients with stage II or III germ cell tumor (GETUG 13). Poster presented at: ASCO Annual Meeting; 2013 May 31-June 4; Chicago.
22. C.R. Nichols, B. Roth, and C. Kollmannsberger Classical clinical trial design in testicular cancer: time to move on J Clin Oncol 30 2012 769 771
23. A.-C. Piketty, A. Fléchon, A. Laplanche, E. Nouyrigat, J.-P. Droz, and C. Théodore et al. The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface area Br J Cancer 93 2005 909 914
24. J.L. Passos-Coelho, M. Castro Ribeiro, E. Santos, C. Sousa Pontes, B. Brito, and A.C. Miranda Suboptimal survival of male germ-cell tumors in Southern Portugal - a population-based retrospective study for cases diagnosed in 1999 and 2000 Ann Oncol 22 2011 1215 1220
25. L. Collette, R.J. Sylvester, S.P. Stenning, S.D. Fossa, G.M. Mead, and R. de Wit et al. Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party J Natl Cancer Inst 91 1999 839 846
26. P. Albers, R. Siener, S. Krege, H.-U. Schmelz, K.-P. Dieckmann, and A. Heidenreich et al. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group J Clin Oncol 26 2008 2966 2972
27. C. Kollmannsberger, S. Daneshmand, A. So, K.N. Chi, N. Murray, and C. Moore et al. Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery J Clin Oncol 28 2010 537 542
28. C. Kollmannsberger, S. Tyldesley, C. Moore, K.N. Chi, N. Murray, and S. Daneshmand et al. Evolution in management of testicular seminoma: population-based outcomes with selective utilization of active therapies Ann Oncol 22 2011 808 814
29. J. Beyer, P. Albers, R. Altena, J. Aparicio, C. Bokemeyer, and J. Busch et al. Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer Ann Oncol 24 2013 878 888